Learn more

CORESTEM CO LTD

Overview
  • Total Patents
    60
  • GoodIP Patent Rank
    98,079
  • Filing trend
    ⇧ 200.0%
About

CORESTEM CO LTD has a total of 60 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2004. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are NANJING GEN HOSP COMMAND PLA, SHANDONG BINZHOU BOLAIWEI BIOTECH CO LTD and TRIZELL LTD.

Patent filings per year

Chart showing CORESTEM CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kim Kyung Suk 58
#2 Choung Jai Jun 24
#3 Kim Seung Hyun 19
#4 Choi Mi Ran 14
#5 Koh Seong Ho 13
#6 Lee Tae Yong 12
#7 Kim Hee Tae 10
#8 Kim Hyun Young 8
#9 Lee Jun Ho 7
#10 Yoon Hyun Soo 7

Latest patents

Publication Filing date Title
WO2021066526A1 Biomarker composition for predicting therapeutic effect of mesenchymal stem cells on systemic lupus erythematosus
WO2021066527A1 Biomarker composition for predicting therapeutic effect of mesenchymal stem cell on renal fibrosis
KR20200061313A Chamber for Transferring Medical Thing
KR20200053992A Pharmaceutical composition comprising stem cells treated with protein kinase c activator or culture thereof for prevention and treatment of autoimmune diseases
KR20200053993A Biomarker for prediction of proliferation and migration capacity of mesenchymal stem cell and use thereof
KR20190142129A Biomarker for treatment of autoimmune diseases, diagnostic kit and the therapeutic use thereof
KR20180109600A Composition for cryopreservation of stem cells having improved cryopreservation effect and method using the same
KR20180027832A Cell Hypothermic Protectants of Bone Marrow Derived Mesenchymal Stem Cell using Artifical Cerebrospinal Fluid
KR20160030387A Pharmaceutical Compositions for Preventing or Treating Autoimmune Diseases Comprising Mesenchymal Stem Cells Derived from Human Bone-Marrow
WO2016017863A1 Pharmaceutical composition for preventing or treating autoimmune diseases, containing human bone marrow-derived mesenchymal stem cells as active ingredient
KR20150059671A Pharmaceutical Compositions for Preventing or Treating Parkinsonism Comprising Mesenchymal Stem Cells Derived from Human Bone-Marrow
KR20130099727A Anti-oxidant compositions for culturing mesenchymal stromal cells and uses thereof
KR20130099707A Anti-oxidant compositions for culturing mesenchymal stem cells and uses thereof
KR20110132086A Peptide gene carrier and method for transfecting gene into adult stem cell using the same
KR20110042468A Compositions for improving migration potential of stem cells
KR20090113357A A Cell Culture Device Having The Cell Culture Flask
KR20080106152A Methods and compostions for treating motor neuron diseases comprising mesenchymal stem cells
KR20100035434A Cell culture tube of syringe shape and multiple cell culture device using the same
KR20100035441A Apparatus for multiple cell culture
KR20090056666A Rotation driving device for cell culturing